Literature DB >> 16282977

Mutations in SIL1 cause Marinesco-Sjögren syndrome, a cerebellar ataxia with cataract and myopathy.

Jan Senderek1, Michael Krieger, Claudia Stendel, Carsten Bergmann, Markus Moser, Nico Breitbach-Faller, Sabine Rudnik-Schöneborn, Astrid Blaschek, Nicole I Wolf, Inga Harting, Kathryn North, Janine Smith, Francesco Muntoni, Martin Brockington, Susana Quijano-Roy, Francis Renault, Ralf Herrmann, Linda M Hendershot, J Michael Schröder, Hanns Lochmüller, Haluk Topaloglu, Thomas Voit, Joachim Weis, Friedrich Ebinger, Klaus Zerres.   

Abstract

SIL1 (also called BAP) acts as a nucleotide exchange factor for the Hsp70 chaperone BiP (also called GRP78), which is a key regulator of the main functions of the endoplasmic reticulum. We found nine distinct mutations that would disrupt the SIL1 protein in individuals with Marinesco-Sjögren syndrome, an autosomal recessive cerebellar ataxia complicated by cataracts, developmental delay and myopathy. Identification of SIL1 mutations implicates Marinesco-Sjögren syndrome as a disease of endoplasmic reticulum dysfunction and suggests a role for this organelle in multisystem disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282977     DOI: 10.1038/ng1678

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  80 in total

1.  Tracking Effects of SIL1 Increase: Taking a Closer Look Beyond the Consequences of Elevated Expression Level.

Authors:  Thomas Labisch; Stephan Buchkremer; Vietxuan Phan; Laxmikanth Kollipara; Christian Gatz; Chris Lentz; Kay Nolte; Jörg Vervoorts; José Andrés González Coraspe; Albert Sickmann; Stephanie Carr; René P Zahedi; Joachim Weis; Andreas Roos
Journal:  Mol Neurobiol       Date:  2017-04-11       Impact factor: 5.590

2.  A novel mutation in the proteolytic domain of LONP1 causes atypical CODAS syndrome.

Authors:  Takehiko Inui; Mai Anzai; Yusuke Takezawa; Wakaba Endo; Yosuke Kakisaka; Atsuo Kikuchi; Akira Onuma; Shigeo Kure; Ichizo Nishino; Chihiro Ohba; Hirotomo Saitsu; Naomichi Matsumoto; Kazuhiro Haginoya
Journal:  J Hum Genet       Date:  2017-02-02       Impact factor: 3.172

Review 3.  All in the family: atypical Hsp70 chaperones are conserved modulators of Hsp70 activity.

Authors:  Lance Shaner; Kevin A Morano
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

Review 4.  [Inflammatory and other myopathies and skeletal muscle vasculitis: the role of muscle and nerve biopsy].

Authors:  J Weis; K Nolte
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

Review 5.  Protein folding in the endoplasmic reticulum.

Authors:  Ineke Braakman; Daniel N Hebert
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

6.  Molecular chaperones of the Hsp110 family act as nucleotide exchange factors of Hsp70s.

Authors:  Zdravko Dragovic; Sarah A Broadley; Yasuhito Shomura; Andreas Bracher; F Ulrich Hartl
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

Review 7.  Roles of the nucleotide exchange factor and chaperone Hsp110 in cellular proteostasis and diseases of protein misfolding.

Authors:  Unekwu M Yakubu; Kevin A Morano
Journal:  Biol Chem       Date:  2018-09-25       Impact factor: 3.915

8.  Interactions between Kar2p and its nucleotide exchange factors Sil1p and Lhs1p are mechanistically distinct.

Authors:  Sarah J Hale; Simon C Lovell; Jeanine de Keyzer; Colin J Stirling
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

9.  Essential role of the unfolded protein response regulator GRP78/BiP in protection from neuronal apoptosis.

Authors:  M Wang; R Ye; E Barron; P Baumeister; C Mao; S Luo; Y Fu; B Luo; L Dubeau; D R Hinton; A S Lee
Journal:  Cell Death Differ       Date:  2009-10-09       Impact factor: 15.828

10.  Alteration of the unfolded protein response modifies neurodegeneration in a mouse model of Marinesco-Sjögren syndrome.

Authors:  Lihong Zhao; Christine Rosales; Kevin Seburn; David Ron; Susan L Ackerman
Journal:  Hum Mol Genet       Date:  2010-01-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.